Virtus Investment Advisers, Inc. Adma Biologics, Inc. Transaction History
Virtus Investment Advisers, Inc.
- $119 Million
- Q4 2024
A detailed history of Virtus Investment Advisers, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 14,980 shares of ADMA stock, worth $237,283. This represents 0.22% of its overall portfolio holdings.
Number of Shares
14,980
Previous 77,897
80.77%
Holding current value
$237,283
Previous $1.56 Million
83.56%
% of portfolio
0.22%
Previous 1.3%
Shares
5 transactions
Others Institutions Holding ADMA
# of Institutions
339Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$295 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$288 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$236 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$179 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$87.7 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.11B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...